Anti-fibrosis activity of combination therapy with epigallocatechin gallate, taurine and genistein by regulating glycolysis, gluconeogenesis, and ribosomal and lysosomal signaling pathways in HSC-T6 cells

A previous study by our group indicated that combined treatment with taurine, epigallocatechin gallate (EGCG) and genistein protects against liver fibrosis. The aim of the present study was to elucidate the antifibrotic mechanism of this combination treatment using isobaric tag for relative and abso...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan, Zhu, Min, Huo, Yani, Zhang, Xuerong, Liao, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257822/
https://www.ncbi.nlm.nih.gov/pubmed/30542382
http://dx.doi.org/10.3892/etm.2018.6743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257822/
https://www.ncbi.nlm.nih.gov/pubmed/30542382
http://dx.doi.org/10.3892/etm.2018.6743

Ejemplares similares